【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Assumptions
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Biosimilars: Overview
• Comparative analysis of generic small molecules and biosimilars
• Biosimilars market opportunities
• Challenges for new entrants
• Bio-betters
PART 05: Pipeline portfolio
PART 06: Market landscape
• Market overview
• Five forces analysis
PART 07: Market segmentation by application
• Global chronic and autoimmune diseases mAb biosimilars market
• Global oncology mAb biosimilars market
PART 08: Geographical segmentation
• Global mAb biosimilars market by geographical segmentation 2015-2020
• mAb biosimilars market in Europe
• mAb biosimilars market in Asia
• mAb biosimilars market in rest of the world
PART 09: Market drivers
• Rise in number of patent expiries
• Need for cost-effective treatment
• Reimbursement benefits for biosimilars
• Favorable government regulations
PART 10: Impact of drivers
PART 11: Market challenges
• Physicians’ reluctance to prescribe biosimilars
• Multiple manufacturing complexities
• Risks related to drug failure
• Limited availability of biosimilar products
• Difficulties in patient recruitment for clinical trials
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Emergence of biosimilars
• Outsourcing of manufacturing activities
• Need for high investment in R&D
• High growth in the emerging markets
• Rising number of strategic collaborations
PART 14: Vendor landscape
• Competitive scenario
PART 15: Key vendor analysis
• Biocon
• Celltrion
• Dr. Reddy’s Laboratories
• Hospira
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Global mAb biosimilars market: Snapshot
Exhibit 03: Global mAb biosimilars market: Growth analysis
Exhibit 04: Global mAb biosimilars market: Key buying criteria 2015
Exhibit 05: Global mAb biosimilars market: Timeline 2014-2020
Exhibit 06: Global mAb biosimilars market: Impact of key customer segments 2015
Exhibit 07: Definition of biosimilars by agencies
Exhibit 08: Comparison between generic small molecules and biosimilars
Exhibit 09: Impact of biosimilars cost savings on different sectors
Exhibit 10: Factors affecting success of biosimilars
Exhibit 11: Biosimilars industry: Point-of-view
Exhibit 12: Factors influencing uptake of biosimilars
Exhibit 13: Global mAb biosimilars market: Strategic factors for new market entrants
Exhibit 14: Challenges for new entrants
Exhibit 15: Bio-betters and its impact on market
Exhibit 16: Global mAb biosimilars market: Pipeline snapshot 2015
Exhibit 17: Pipeline portfolio: Global mAb biosimilars market 2015
Exhibit 18: Patent expiry in key mAb biosimilars markets 2000-2020
Exhibit 19: Global mAb biosimilars market: Developed and emerging markets 2015
Exhibit 20: Global mAb biosimilars market 2015-2020 ($ millions)
Exhibit 21: Biosimilars: Savings potential in five European countries and US ($ billions) 2016-2020
Exhibit 22: Global spending on mAb biosimilars 2010-2020 ($ billions)
Exhibit 23: Global mAb biosimilars market: Key metrics analysis snapshot
Exhibit 24: Current and future trends in global mAb biosimilars market
Exhibit 25: Factors influencing the global mAb biosimilars market 2015
Exhibit 26: Five forces analysis
Exhibit 27: Global mAb biosimilars market: Segmentation by application (2015-2020)
Exhibit 28: Applications of mAb biosimilars and its impact on growth of market
Exhibit 29: Global mAb biosimilars market segmentation: Growth cycle analysis
Exhibit 30: Population aged 60 years and over (millions)
Exhibit 31: Global chronic and autoimmune diseases mAb biosimilars market 2015-2020 ($ millions)
Exhibit 32: Opportunity analysis of chronic and autoimmune diseases mAb biosimilars market by application
Exhibit 33: Global incidence of cancer 2015-2020 (millions)
Exhibit 34: Global oncology mAb biosimilars market 2015-2020 ($ millions)
Exhibit 35: Opportunity analysis of global oncology mAb biosimilars market by type of application
Exhibit 36: Global mAb biosimilars market segmentation by application 2015
Exhibit 37: Global mAb biosimilars market by geography: Outlook 2015-2020
Exhibit 38: Global mAb biosimilars market by geography 2015
Exhibit 39: Market penetration of originators and biosimilars by region/country
Exhibit 40: Global mAb biosimilars market landscape: Country analysis
Exhibit 41: mAb biosimilars market in Europe: Opportunity analysis
Exhibit 42: mAb biosimilars market in Europe 2015-2020 ($ millions)
Exhibit 43: PEST analysis: mAb biosimilars market in Europe 2015
Exhibit 44: mAb biosimilars market in Asia: Opportunity analysis
Exhibit 45: mAb biosimilars market in Asia 2015-2020 ($ millions)
Exhibit 46: PEST analysis: mAb biosimilars market in Asia 2015
Exhibit 47: mAb biosimilars market in rest of the world: Opportunity analysis
Exhibit 48: mAb biosimilars market in rest of the world 2015-2020 ($ millions)
Exhibit 49: Benefits of mAb biosimilars to US healthcare system
Exhibit 50: PEST analysis: mAb biosimilars market in rest of the world 2015
Exhibit 51: Impact of drivers and challenges on global mAb biosimilars market
Exhibit 52: Patent analysis of mAb in the US
Exhibit 53: Patent analysis of biologicals in Europe
Exhibit 54: Impact of drivers
Exhibit 55: Physicians’ reluctance to prescribe biosimilars: Key reasons
Exhibit 56: Impact of drivers and challenges
Exhibit 57: Global mAb biosimilars market: Impact assessment of key trends
Exhibit 58: Competitive assessment of vendors
Exhibit 59: Key vendors: Geographical presence 2015
Exhibit 60: Major vendors in global mAb biosimilars market: Mergers, acquisitions, and partnerships
Exhibit 61: Biocon profile
Exhibit 62: Biocon: Metrics analysis
Exhibit 63: Biocon growth strategy matrix
Exhibit 64: Biocon: Opportunity assessment
Exhibit 65: Celltrion profile
Exhibit 66: Celltrion: Metrics analysis
Exhibit 67: Celltrion growth strategy matrix
Exhibit 68: Celltrion: opportunity assessment
Exhibit 69: Dr. Reddy’s Laboratories profile
Exhibit 70: Dr. Reddy’s Laboratories: Metrics analysis
Exhibit 71: Dr. Reddy’s Laboratories growth strategy matrix
Exhibit 72: Dr. Reddy’s Laboratories Opportunity assessment
Exhibit 73: Hospira profile
Exhibit 74: Hospira: Metrics analysis
Exhibit 75: Hospira growth strategy matrix
Exhibit 76: Hospira opportunity growth assessment
【レポート販売概要】
■ タイトル：モノクローナル抗体（mAb）バイオシミラーの世界市場2016-2020■ 英文：Global mAb Biosimilars Market 2016-2020
■ 発行日：2016年9月23日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10349
■ 調査対象地域：グローバル
- 世界のグラスウール絶縁材料市場2015The Global Glass Wool Insulation Material Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Glass Wool Insulation Material industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Glass Wool Insulation Material market analysis is provided for the internati …
- 2014年戦略提言：Echovirusの診断検査市場The report presents a detailed analysis of the Echovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Echovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- 切傷抵抗グローブの世界市場2019-2023About this market The rising risks of physical injuries associated with labor-intensive industries will lead the cut resistant gloves market to register significant growth during the forecast period. Labor-intensive industries including the construction, manufacturing, chemicals, and food processing are prone to injuries including the abrasion cuts, slicing cuts, and impact cuts. As a result, incr …
- 世界の小型自動車用OEコネクティビティ（ネットワーク接続）市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE connected vehicle sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE connected vehicle market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies …
- 血漿分画の世界市場：製品別（アルブミン、免疫グロブリン、凝固第VIII因子）、用途別（神経学、血液学、免疫学、救命救急、その他）、エンドユーザー別（病院、研究所）The global plasma fractionation market was valued at $16,823 million in 2018, and is expected to reach $30,536 million by 2026, registering a CAGR of 6.1% from 2019 to 2026. Fractionation is a mechanical process carried out to separate a certain quantity of mixture. Plasma is the liquid part of the blood which is yellowish and holds blood cells. Plasma fractionation is carried out to separate high …
- Oil Search Limited：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Oil Search Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Oil Search Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- 世界のタンポン（Tampons）市場動向（2014-2018）TechNavio's analysts forecast the Global Tampons market to grow at a CAGR of 6.10 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased awareness. The Global Tampons market has also been witnessing the increasing demand from emerging economies. However, the increasing vendor competition could pose a challenge to the growth of this market. Tec …
- 戦場における拡張現実（Augmented Reality in the Battlefield 2012 – 2016）Augmented Reality or simply AR is a live, direct or indirect, view of a physical, real-world environment whose elements are augmented by computer-generated sensory input, that enrich the user's perception of the real world. Although AR is often perceived to be in the visual domain (video or graphics etc), it actually includes the other senses as well such as sound or GPS data. With its roots datin …
- OSI Systems, Inc.：市場シェア分析OSI Systems, Inc. Market Share Analysis Summary GlobalData’s new report, “OSI Systems, Inc. Market Share Analysis” provides in-depth information on OSI Systems, Inc.’s market position in the different medical equipment markets it operates in. The report provides OSI Systems, Inc. market share information in seven key market categories – Multiparameter Patient Monitoring, Neonatal Monitors, Cardiov …
- Abraxas Petroleum Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Abraxas Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Abraxas Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an …
- 世界のヒ素市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of arsenic, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing arsenic production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: arsenic product …
- 世界のウイルス及び細菌検査（医療機器）市場：サプライヤーシェア及び市場予測Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. “Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in the U.S. …
- 医療用複合材料の世界市場予測：炭素繊維、セラミック繊維、ガラス繊維The global medical composites market is projected to grow from USD 663.3 Million in 2016 to USD 934.7 Million by 2021, at a CAGR of 7.10% during the forecast period. The medical composites market is growing because of high demand for diagnostic imaging application as they are radiolucent and do not hinder the diagnosis process. Medical composites manufactured using carbon fiber has advantages such …
- 断熱包装の世界市場Insulated packaging market includes types, such as boxes & containers, bags & pouches, wraps, and others. The insulated packaging market has varied applications, such as food & beverages, industrial, pharmaceutical, cosmetic, and others. Insulated packaging possesses a unique quality of thermal insulation from the external environment, which fuels the insulated packaging market. The market for ins …
- 火災、煙、および毒耐性 (FST) 複合樹脂の世界市場予測（～2020）：フェノール樹脂、エポキシ樹脂、ポリエステル樹脂、熱可塑性樹脂The global ‘Fire, Smoke, and Toxicity Retardant (FST) Composite Resin’ market is projected to reach USD 835.2 Million by 2020, witnessing a CAGR of 8.5% between 2015 and 2020. The increasing number of patents filed for FST composite resin by global players, introduction of stringent public safety norms, growing demand for FST composite, new product launches, continuous agreements, joint ventures & …
